MYO is a research peptide studied for its role in myostatin pathway regulation. Myostatin (GDF-8) is a negative regulator of skeletal muscle growth, and compounds inhibiting its activity are of significant interest in muscle biology, muscular dystrophy research, and sarcopenia models. Research has explored myostatin-inhibiting peptides for their ability to promote muscle fiber hypertrophy, reduce atrophy in wasting models, and improve body composition in preclinical subjects. PeptideBull provides MYO at research-grade purity for authorized laboratory research. Not intended for human or veterinary consumption.
Research Articles
BPC-157 Research Mechanisms: A Deep Dive into Healing Pathways
Discover the scientific foundation behind BPC-157's healing potential. This article explores the key research mechanisms...
Adipotide FTPP: Targeting Adipose Vasculature Research
Adipotide FTPP is a novel research peptide investigated for its effects on adipose tissue. This article delves into its...
Thymosin Alpha-1 Immune Modulation Research: A Deep Dive for Scientists
Thymosin Alpha-1 (TA1) is a naturally occurring thymic peptide extensively studied for its profound immunomodulatory pro...